全文获取类型
收费全文 | 80933篇 |
免费 | 11209篇 |
国内免费 | 519篇 |
专业分类
耳鼻咽喉 | 969篇 |
儿科学 | 2532篇 |
妇产科学 | 1945篇 |
基础医学 | 9172篇 |
口腔科学 | 2288篇 |
临床医学 | 13263篇 |
内科学 | 16526篇 |
皮肤病学 | 1737篇 |
神经病学 | 8135篇 |
特种医学 | 2354篇 |
外国民族医学 | 20篇 |
外科学 | 9237篇 |
综合类 | 1608篇 |
现状与发展 | 3篇 |
一般理论 | 47篇 |
预防医学 | 9328篇 |
眼科学 | 1494篇 |
药学 | 4873篇 |
4篇 | |
中国医学 | 629篇 |
肿瘤学 | 6497篇 |
出版年
2023年 | 1767篇 |
2022年 | 862篇 |
2021年 | 2562篇 |
2020年 | 2399篇 |
2019年 | 2287篇 |
2018年 | 3579篇 |
2017年 | 3154篇 |
2016年 | 3253篇 |
2015年 | 3487篇 |
2014年 | 4272篇 |
2013年 | 5121篇 |
2012年 | 5455篇 |
2011年 | 5713篇 |
2010年 | 3916篇 |
2009年 | 3790篇 |
2008年 | 4432篇 |
2007年 | 4304篇 |
2006年 | 4148篇 |
2005年 | 3739篇 |
2004年 | 3311篇 |
2003年 | 2987篇 |
2002年 | 2898篇 |
2001年 | 1568篇 |
2000年 | 1368篇 |
1999年 | 1361篇 |
1998年 | 822篇 |
1997年 | 731篇 |
1996年 | 644篇 |
1995年 | 627篇 |
1994年 | 489篇 |
1993年 | 424篇 |
1992年 | 680篇 |
1991年 | 630篇 |
1990年 | 584篇 |
1989年 | 553篇 |
1988年 | 555篇 |
1987年 | 459篇 |
1986年 | 447篇 |
1985年 | 427篇 |
1984年 | 307篇 |
1983年 | 237篇 |
1982年 | 165篇 |
1981年 | 139篇 |
1980年 | 113篇 |
1979年 | 221篇 |
1978年 | 128篇 |
1977年 | 137篇 |
1976年 | 124篇 |
1974年 | 138篇 |
1972年 | 137篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
Marco N. Iannone Stefano Stucchi Elia A. Turolla Chiara Beretta Samuele Ciceri Clizia Chinello Lisa Pagani Sergio Todde Patrizia Ferraboschi 《Journal of labelled compounds & radiopharmaceuticals》2022,65(3):48-62
In the last decade, the development of new radiopharmaceuticals for the imaging and therapy of prostate cancer has been a highly active and important area of research, especially focusing on the prostate-specific membrane antigen (PSMA), an antigen which is upregulated in prostate, as well as in other tumor cells. A large variety of PSMA ligands have been radiolabeled, to date. Among the various derivatives, PSMA-617 resulted to be one of the most interesting in terms of interaction with the antigen and clinical properties, and its lutetium-177 labeled version has recently been approved by regulatory agencies for therapeutic purposes. For this reasons, the radiolabeling with fluorine-18 of a PSMA-617 derivative might be of interest. Beside other methodologies to radiolabel macromolecules with fluorine-18, the “click-chemistry” approach resulted to be very useful, and the copper-catalyzed azide-alkyne cycloaddition (CuAAC) is considered one of most efficient and reliable. This paper proposes the synthesis of a suitable precursor for the radiolabeling with fluorine-18 of a new PSMA-617 derivative. The whole radiosynthetic procedure has been fully automated, and the final product, which proved to be stable in plasma, has been obtained with radiochemical yield and purity suitable for subsequent preclinical studies. 相似文献
2.
Hommes Franziska Mohsenpour Amir Kropff Dana Pilgram Lisa Matusall Svenja von Philipsborn Peter Sell Kerstin 《Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz》2022,65(1):96-106
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz - Akteure der öffentlichen Gesundheit (Public Health) tragen wesentlich zu Gesundheitsschutz, -förderung und... 相似文献
3.
4.
5.
6.
Nicolas Penel Sylvie Bonvalot Marie-Cécile Le Deley Antoine Italiano Camille Tlemsani Diane Pannier Clémence Leguillette Jean-Emmanuel Kurtz Maud Toulmonde Julien Thery Daniel Orbach Pascale Dubray-Longeras Benjamin Verret François Bertucci Cécile Guillemet Lucie Laroche Armelle Dufresne Jean-Yves Blay Axel Le Cesne 《International journal of cancer. Journal international du cancer》2023,153(2):407-416
The aim of this study is to evaluate the prevalence, determinants and prognostic value of pain at diagnosis in patients with desmoid-type fibromatosis (DF). We selected patients from the ALTITUDES cohort (NCT02867033), managed by surgery, active surveillance or systemic treatments, with pain assessment at diagnosis. Patients were invited to fill QLQ-C30 questionnaire and Hospital Anxiety Depression Scale. Determinants were identified using logistic models. Prognostic value on event-free survival (EFS) was evaluated using the Cox model. Overall, 382 patients were included in the current study (median age: 40.2 years; 117 men). The prevalence of pain was 36%, without significant difference according to first-line treatment (P = .18). In the multivariate analysis, pain was significantly associated with tumor size >50 mm (P = .013) and tumor site (P < .001); pain was more frequent in the neck and shoulder locations (odds ratio: 3.05 [1.27-7.29]). Pain at baseline was significantly associated with poor quality of life (P < .001), depression (P = .02), lower performance status (P = .03) and functional impairment (P = .001); we also observed a nonsignificant association with anxiety (P = .10). In the univariate analysis, baseline pain was associated with poor EFS; the 3-year EFS was 54% in patients with pain compared to 72% in those without pain. After adjustment for sex, age, size and line of treatment, pain was still associated with poor EFS (hazard ratio: 1.82 [1.23-2.68], P = .003). One third of recently diagnosed patients with DF experienced pain, especially those with larger tumors and neck/shoulder locations. Pain was associated with unfavorable EFS after adjustment for the confounders. 相似文献
7.
8.
9.
Psychiatric Quarterly - While COVID-19 has had widespread impact on the way behavioral health services are delivered, very little research exists characterizing how providers have perceived these... 相似文献
10.
Background:Acute ischemic stroke (AIS) is an important factor leading to adult death and disability globally. For AIS patients who meet certain conditions, recombinant tissue plasminogen activator (rt-PA) intravenous thrombolysis is an important method recommended by national guidelines to achieve vascular recanalization. However, complications such as hemorrhagic transformation and vascular reocclusion after thrombolysis are still unsolved problems in clinical. Several systematic reviews of clinical randomized controlled trials (RCTs) in the past have shown that Chinese herbal injections (CHIs) can improve the neurological function of patients, increase the tolerance of ischemic tissues to hypoxia, and inhibit platelet aggregation. Therefore, this study conducted a meta-analysis of AIS treatment with intravenous thrombolysis alone and compared it with the combined application of CHIs. To evaluate whether CHIs have a synergistic effect on thrombolytic therapy and provide a basis for clinical application.Methods:The following databases will be searched until September 2020: ①English databases: PubMed, Cochrane Library, Embase; ②Chinese databases: CNKI, Wanfang database, Weipu database, SinoMed. RCTs will be included to compare the efficacy of thrombolysis combined with CHIs and thrombolysis alone in the treatment of AIS. Data extraction and risk of bias assessments will be carried out by 2 verifiers independently. The risk of bias will be evaluated through the Cochrane risk of bias tool. Review Manager software 5.3 will be used for statistical analysis.Results:This study will provide comprehensive evidence for the treatment of AIS by CHIs combined with intravenous thrombolysis from multiple aspects.Conclusion:The conclusion of the meta-analysis will provide a basis for judging whether CHIs combined with intravenous thrombolysis is an effective measure for the treatment of AIS.Ethics and dissemination:Ethical approval is not needed because this study will be based on data that already published. We will publish the findings of this study in a peer-reviewed journal and related conferences.PROSPERO registration number:CRD42020215546. 相似文献